SCHEMBL6435977

SCHEMBL6435977

C/C=C/COCc1c(I)ccnc1OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6435979 1.00
SCHEMBL6760404 0.80 AURKA (0.30)
SCHEMBL10048733 0.75
SCHEMBL6627639 0.74
SCHEMBL616429 0.73
SCHEMBL616428 0.73
SCHEMBL4405916 0.73 AURKA (0.33)
SCHEMBL4402294 0.73 AURKA (0.33)
SCHEMBL31437498 0.73 AURKA (0.33)
SCHEMBL23922826 0.72 CCNB2 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025077773-A1 NOVEL TYPE I TOPOISOMERASE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海翊维康医药有限责任公司 2025-04-17 WO disclosed
WO-2025077767-A1 NOVEL I-TYPE TOPOISOMERASE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海翊维康医药有限责任公司 2025-04-17 WO disclosed
EP-1254908-B9 Preparation of a camptothecin derivative by intramolecular cyclisation OSI PHARM INC (US) 2005-09-21 EP disclosed
EP-1254908-B1 Preparation of a camptothecin derivative by intramolecular cyclisation OSI PHARM INC (US) 2005-02-23 EP disclosed
US-6821982-B2 Preparation of a camptothecin derivative by intramolecular cyclisation OSI PHARMACEUTICALS, INC. 2004-11-23 US disclosed
EP-0758333-B1 INTERMEDIATES IN PHARMACEUTICAL CAMPTOTHECIN PREPARATION OSI PHARM INC (US) 2004-03-03 EP disclosed
US-20030204088-A1 Preparation of a camptothecin derivative by intramolecular cyclisation OSI PHARMACEUTICALS, INC. 2003-10-30 US disclosed
US-6559309-B2 Preparation for camptothecin and camptothecin-like compounds and to novel intermediates used in this preparation. The process for the preparation of the camptothecin derivative known by 7-(4 OSI PHARMACEUTICALS, INC. 2003-05-06 US disclosed
US-20030045719-A1 Preparation of a camptothecin derivative by intramolecular cyclisation OSI PHARMACEUTICALS, INC. 2003-03-06 US disclosed
EP-1254908-A1 Preparation of a camptothecin derivative by intramolecular cyclisation GILEAD SCIENCES, INC. (US) 2002-11-06 EP disclosed
EP-0758335-B1 PREPARATION OF A CAMPTOTHECIN DERIVATIVE BY INTRAMOLECULAR CYCLISATION GILEAD SCIENCES INC (US) 2002-11-06 EP disclosed
US-6462196-B1 NOVEL INTERMEDIATES USED IN THE PREPARATION OF CAMPTOTHECIN DERIVATIVES OSI PHARMACEUTICALS, INC. 2002-10-08 US disclosed
US-6063923-A Preparation of a camptothecin derivative by intramolecular cyclisation GLAXO WELLCOME INC. (US) 2000-05-16 US disclosed
US-5840898-A Method of removing heavy metal contaminants from organic compounds GLAXO WELLCOME, INC. (US) 1998-11-24 US disclosed
EP-0758333-A1 INTERMEDIATES IN PHARMACEUTICAL CAMPTOTHECIN PREPARATION GLAXO WELLCOME INC. (US) 1997-02-19 EP disclosed
EP-0758335-A1 PREPARATION OF A CAMPTOTHECIN DERIVATIVE BY INTRAMOLECULAR CYCLISATION GLAXO WELLCOME INC. (US) 1997-02-19 EP disclosed
US-5491237-A Intermediates in pharmaceutical camptothecin preparation GLAXO WELLCOME INC. (US) 1996-02-13 US disclosed
WO-1995029917-A2 INTERMEDIATES IN PHARMACEUTICAL CAMPTOTHECIN PREPARATION GLAXO WELLCOME INC. (US) 1995-11-09 WO disclosed
WO-1995029919-A1 PREPARATION OF A CAMPTOTHECIN DERIVATIVE BY INTRAMOLECULAR CYCLISATION GLAXO WELLCOME INC. (US) 1995-11-09 WO disclosed